Loading…
Antitumoral activity of quinoxaline derivatives: A systematic review
Cancer is a leading cause of death and a major health problem worldwide. While many effective anticancer agents are available, the majority of drugs currently on the market are not specific, raising issues like the common side effects of chemotherapy. However, recent research hold promise for the de...
Saved in:
Published in: | European journal of medicinal chemistry 2019-02, Vol.163, p.136-147 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cancer is a leading cause of death and a major health problem worldwide. While many effective anticancer agents are available, the majority of drugs currently on the market are not specific, raising issues like the common side effects of chemotherapy. However, recent research hold promise for the development of more efficient and safer anticancer drugs. Quinoxaline and its derivatives are becoming recognized as a novel class of chemotherapeutic agents with activity against different tumors. The present review compiles and discusses studies concerning the therapeutic potential of the anticancer activity of quinoxaline derivatives, covering articles published between July 2013 and July 2018.
[Display omitted]
•Quinoxaline is a nitrogen containing a heterocyclic compound formed by the fusion of benzene and pyrazine.•Many drug candidates bearing quinoxaline moiety are currently under clinical trials for anticancer therapeutic purposes.•A systematic review on antitumoral activities linked to quinoxaline derivatives was carried out.•This review will be helpful for medicinal chemists in the development of useful anticancer therapeutics. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2018.11.059 |